Nathan D Montgomery
Overview
Explore the profile of Nathan D Montgomery including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
1165
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gioulbasani M, Aijo T, Liu S, Montgomery S, Montgomery N, Corcoran D, et al.
Commun Biol
. 2024 Dec;
7(1):1606.
PMID: 39627458
Ten eleven translocation (TET) proteins are tumor suppressors that through their catalytic activity oxidize 5-methylcytosine to 5-hydroxymethylcytosine, to promote DNA demethylation and to regulate gene expression. Notably, TET2 is one...
2.
Jacobson T, Bae Y, Kler J, Iyer R, Zhang R, Montgomery N, et al.
Environ Sci Technol
. 2024 Feb;
58(8):3580-3594.
PMID: 38354120
Mycotoxins are a heterogeneous group of toxins produced by fungi that can grow in staple crops (e.g., maize, cereals), resulting in health risks due to widespread exposure from human consumption...
3.
Johnson S, Haberberger J, Galeotti J, Ramkissoon L, Coombs C, Richardson D, et al.
Leuk Lymphoma
. 2023 Nov;
65(2):209-218.
PMID: 37921062
A large-scale genomic analysis of patients with -mutated myeloid disease has not been performed to date. We reviewed comprehensive genomic profiling results from 6043 adults to characterize clinicopathologic features and...
4.
Johnson S, Haberberger J, Galeotti J, Ramkissoon L, Coombs C, Richardson D, et al.
Blood Cancer J
. 2023 Jun;
13(1):96.
PMID: 37365170
No abstract available.
5.
Kumar V, Montgomery N, van Deventer H, Whang Y
J Med Case Rep
. 2023 May;
17(1):220.
PMID: 37245043
Background: Hypoproliferative anemia is a frequently encountered adverse event in cancer patients receiving immune checkpoint inhibitors (ICI). Secondary pure red cell aplasia (PRCA) is a rare but recognized immune related...
6.
Jensen C, Montgomery N, Galeotti J, Foster M, Zeidner J
J Cell Mol Med
. 2022 Nov;
26(24):6079-6082.
PMID: 36444394
No abstract available.
7.
Jacobson T, Kler J, Bae Y, Chen J, Ladror D, Iyer R, et al.
J Expo Sci Environ Epidemiol
. 2022 Nov;
33(4):672.
PMID: 36323920
No abstract available.
8.
Jacobson T, Kler J, Bae Y, Chen J, Ladror D, Iyer R, et al.
J Expo Sci Environ Epidemiol
. 2022 Aug;
33(4):505-523.
PMID: 35963945
Background: Dried blood spot (DBS) sampling is a simple, cost-effective, and minimally invasive alternative to venipuncture for measuring exposure biomarkers in public health and epidemiological research. DBS sampling provides advantages...
9.
Zeidner J, Vincent B, Ivanova A, Moore D, McKinnon K, Wilkinson A, et al.
Blood Cancer Discov
. 2021 Nov;
2(6):616-629.
PMID: 34778801
Significance: Immune-checkpoint blockade with pembrolizumab was tolerable and feasible after high-dose cytarabine in R/R AML, with encouraging clinical activity, particularly in refractory AML and those receiving treatment as first salvage...
10.
Montgomery N, Galeotti J, Johnson S, Commander L, Weimer E, Chandra P, et al.
Blood Adv
. 2021 Sep;
5(24):5612-5616.
PMID: 34581783
Rare hematologic malignancies display evidence of both myeloid and lymphoid differentiation. Here, we describe such a novel bilineal event discovered in an adult woman with B-lymphoblastic leukemia (BLL). At the...